Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (461-470 of 490) with videos related to

Pageof 49
Sort By:
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
The Journal of Urology|December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trialTeresa L Kauf, Robert S Svatek, Gilad Amiel, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological AssociationRobert P Myers, Narihito Seki, Momokazu Gotoh, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
JAMA Surgery|May 10, 2023
Effects of Specialist Palliative Care for Patients Undergoing Major Abdominal Surgery for Cancer: A Randomized Clinical TrialMyrick C Shinall, Sara F Martin, Mohana Karlekar, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Urologic Oncology|January 16, 2025
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancerSiamak Daneshmand, Ashish M Kamat, Neal D Shore, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Pageof 49

Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
The Journal of Urology|December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trialTeresa L Kauf, Robert S Svatek, Gilad Amiel, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting of the American Urological AssociationRobert P Myers, Narihito Seki, Momokazu Gotoh, et al.
World Journal of Urology|May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinomaGeorgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
JAMA Surgery|May 10, 2023
Effects of Specialist Palliative Care for Patients Undergoing Major Abdominal Surgery for Cancer: A Randomized Clinical TrialMyrick C Shinall, Sara F Martin, Mohana Karlekar, et al.
Urologia Internationalis|July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral CarcinomaGeorgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
The American Journal of Pathology|April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder CancerOpal L Reddy, Justin M Cates, Lan L Gellert, et al.
Urologic Oncology|January 16, 2025
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancerSiamak Daneshmand, Ashish M Kamat, Neal D Shore, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Pageof 49